Trial Search
Current Search Criteria:
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
PHASE3The objective is to evaluate the safety of paricalcitol capsules in pediatr...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01382212
Treatments Being Tested
Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
N/AThe purpose of this study is to identify genes that are responsive to paric...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2009-12
Trial ID
NCT02018133
Treatments Being Tested
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
PHASE4Protocol HECT00306 aims to determine clinically appropriate doses of Hector...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00463021
Treatments Being Tested
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
PHASE3The objective of this study is to determine whether paricalcitol is safe an...
Status
Completed
Location
UCI Medical Center
Start Date
2002-02
Trial ID
NCT00048438
Treatments Being Tested
Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
PHASE3The objective of this study is to determine the safety and efficacy of Zemp...
Status
Completed
Location
California Institute of Renal Research
Start Date
2004-08
Trial ID
NCT00091975
Treatments Being Tested
Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis
N/AParicalcitol capsules (Zemplar®) received marketing authorization in Sweden...
Status
Completed
Location
Site Reference ID/Investigator# 47723
Start Date
2011-02
Trial ID
NCT01265992
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
PHASE4We hypothesize that paricalcitol and calcitriol in dose-dependent manner ar...
Status
Completed
Location
De Haar Research Foundation
Start Date
2009-10
Trial ID
NCT01265615
Treatments Being Tested
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)
PHASE3The objective of this study is to determine whether paricalcitol is safe an...
Status
Completed
Location
VA Greater Los Angeles Healthcare System, West Los Angeles
Start Date
2002-02
Trial ID
NCT00048516
Treatments Being Tested
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
PHASE2The risk of fracture for kidney transplant recipients is 4 times higher tha...
Status
Completed
Location
Mario Negri Institute - Clinical Research Center for Rare Diseases
Start Date
2009-09
Trial ID
NCT01220050
Treatments Being Tested
The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
PHASE3To evaluate the effects of paricalcitol capsules on cardiac structure and f...
Status
Completed
Location
Site Reference ID/Investigator# 8062
Start Date
2008-02
Trial ID
NCT00497146
Treatments Being Tested